Bruno Giroux is an Independent consultant with more than 35 years of experience in the field of oncology. Previously Director of clinical oncology R&D at Servier International Research Institute, then Medical Director of the Onco-Hematology Business Unit at Roche, Scientific and Medical Manager at Bioalliance, Associate Director Medical Affairs at CAC, a CRO in oncology, and Clinical Development Oncology Manager at Rock.
Current role
Scientific Advisor And Co-founder at Transformative
Managing Partner & Senior Scientific Advisor at Brookline Capital Markets
Chair of the Scientific Advisory Board at Therini Bio, Inc.
Scientific Advisor at zPREDICTA
Co-Founder and Scientific Advisor at Amorphology, Inc